NW
BIIB icon

NewEdge Wealth’s Biogen BIIB Stock Holding History

NewEdge Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,470
Closed -$435K – 1141
2025
Q4 		$435K Buy
+2,470
New +$404K ﹤0.01% 896
2024
Q4 		– Sell
-1,142
Closed -$221K – 921
2024
Q3 		$221K Sell
1,142
-219
-16% -$45.8K ﹤0.01% 815
2024
Q2 		$316K Sell
1,361
-13,134
-91% -$2.85M 0.01% 635
2024
Q1 		$3.09M Buy
14,495
+13,114
+950% +$3.07M 0.07% 242
2023
Q4 		$357K Sell
1,381
-21
-1% -$5.16K 0.01% 580
2023
Q3 		$360K Buy
1,402
+50
+4% +$13.4K 0.01% 509
2023
Q2 		$385K Sell
1,352
-76
-5% -$22.6K 0.01% 503
2023
Q1 		$397K Sell
1,428
-457
-24% -$126K 0.02% 454
2022
Q4 		$522K Sell
1,885
-491
-21% -$139K 0.02% 361
2022
Q3 		$634K Sell
2,376
-267
-10% -$56.7K 0.03% 319
2022
Q2 		$539K Buy
2,643
+889
+51% +$182K 0.02% 376
2022
Q1 		$369K Buy
+1,754
New +$381K 0.02% 337

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

NewEdge Wealth's BIIB Position: Q1 2026 in Review

NewEdge Wealth sold out of Biogen (BIIB) in Q1 2026, closing a stake of 2,470 shares — an estimated $435K sold.

NewEdge Wealth first reported a position in BIIB in Q1 2022 and held it in 12 quarters. The position peaked at $3.09M in Q1 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • NewEdge Wealth reported no remaining Biogen position as of Q1 2026 after selling out during the quarter.
  • NewEdge Wealth sold 2,470 Biogen shares in Q1 2026, an estimated $435K.
  • NewEdge Wealth first reported a position in Biogen in Q1 2022 and held it in 12 quarters.
  • NewEdge Wealth's Biogen position peaked at $3.09M in Q1 2024.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.